secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axsome Therapeutics, Inc. (AXSM)
CIK:        0001579428
Form:       8-K
Filed at:   2023-06-26T23:59:59+00:00
Accession:  0000950170-23-029901
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axsome Therapeutics dismisses Ernst & Young, appoints Deloitte as auditor
-------------------------------------------------------------------------

- Audit Committee approved dismissal of Ernst & Young and engagement of Deloitte & Touche for FY2023, effective June 30, 2023.
- Ernst & Young's reports on FY2021 and FY2022 financials were unqualified; no disagreements or reportable events.
- No consulting with Deloitte prior to engagement on accounting principles or audit matters.
- Ernst & Young furnished a letter agreeing with the disclosures, attached as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1579428/000095017023029901/0000950170-23-029901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1579428/000095017023029901/axsm-20230622.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-029901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer